126 related articles for article (PubMed ID: 16271075)
1. Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia/lymphoma.
Nishioka C; Takemoto S; Kataoka S; Yamanaka S; Moriki T; Shoda M; Watanabe T; Taguchi H
Cancer Sci; 2005 Nov; 96(11):810-5. PubMed ID: 16271075
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.
Higuchi M; Matsuda T; Mori N; Yamada Y; Horie R; Watanabe T; Takahashi M; Oie M; Fujii M
Retrovirology; 2005 May; 2():29. PubMed ID: 15876358
[TBL] [Abstract][Full Text] [Related]
4. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of multidrug resistance protein in adult T-cell leukemia.
Ohno N; Tani A; Chen ZS; Uozumi K; Hanada S; Akiba S; Ren XQ; Furukawa T; Sumizawa T; Arima T; Akiyama SI
Clin Cancer Res; 2001 Oct; 7(10):3120-6. PubMed ID: 11595704
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
[TBL] [Abstract][Full Text] [Related]
8. Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia/lymphoma (ATLL) in US/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy.
Yao J; Gottesman SR; Ayalew G; Braverman AS; Axiotis CA
Am J Surg Pathol; 2013 Sep; 37(9):1407-12. PubMed ID: 23797717
[TBL] [Abstract][Full Text] [Related]
9. Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells.
Shimauchi T; Kabashima K; Tokura Y
Cancer Sci; 2008 Jan; 99(1):98-106. PubMed ID: 17970785
[TBL] [Abstract][Full Text] [Related]
10. Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers.
Uozumi K; Uematsu T; Otsuka M; Nakano S; Takatsuka Y; Iwahashi M; Hanada S; Arima T
Am J Hematol; 1996 Nov; 53(3):165-8. PubMed ID: 8895686
[TBL] [Abstract][Full Text] [Related]
11. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
Bittencourt AL; Barbosa HS; Vieira MD; Farré L
Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
13. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
[TBL] [Abstract][Full Text] [Related]
14. [The relation between clinical features of adult T-cell leukemia/lymphoma and the serum levels of soluble CD25 and CD30].
Takemoto S; Pornkuna R; Hidaka M; Kawano F
Rinsho Ketsueki; 2016 Jul; 57(7):848-53. PubMed ID: 27498727
[TBL] [Abstract][Full Text] [Related]
15. [Serum deoxythymidine kinase in adult T-cell leukemia and its related disorders].
Sadamori N; Yamaguchi K; Ikeda S; Hakariya S; Mine M; Itoyama T; Iwasaki H; Kinoshita H; Hayashi K; Ichimaru M
Rinsho Ketsueki; 1990 Nov; 31(11):1812-7. PubMed ID: 2287066
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and experimental study of 9 cases of adult T cell leukemia].
Hu J; Lu L; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):73-5. PubMed ID: 11601202
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
19. Plasma soluble CD30 level correlates negatively with age in children.
Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
[TBL] [Abstract][Full Text] [Related]
20. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
